Updates

** Pfizer's PFE.N shares rise 4.4% to $24.06

** Stock set for its biggest single-day pct. jump in nearly 4 months, if gains hold

** PFE posts Q1 adj. EPS of $0.92, beating analysts' estimates of $0.67, according to data compiled by LSEG

** PFE's Q1 revenue misses estimates due to declining sales of its Paxlovid COVID-19 treatment, but co still sticks by FY revenue forecast of $61 billion-$64 billion

** Co says it would generate $1.7 billion more in savings from cost-cutting to its manufacturing and research operations

** Including session's moves, PFE has fallen about 10% YTD

(Reporting by Siddhi Mahatole)

((siddhi.mahatole@thomsonreuters.com))